We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Beximco Pharma | LSE:BXP | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 36.50 | 35.00 | 38.00 | 36.50 | 36.50 | 36.50 | 0 | 08:00:00 |
Date | Subject | Author | Discuss |
---|---|---|---|
03/8/2017 00:23 | $30m market is pathetic... | zcaprd7 | |
25/7/2017 10:26 | confirmation RNS for 4th drug today. 'along with our growing pipeline' suggests more approvals to come IMHO. | mfhmfh | |
24/7/2017 21:42 | Drug no. 4 approved by FDA, no RNS. | cockneytrader | |
12/7/2017 11:43 | I am very happy with this one i have the main part of this stock and i don't trade and i keep topping up when go to 54 and sell almost all i topped up every time get to 63 keep the profit in share so far as worked quite few times | jovi1 | |
28/6/2017 09:41 | Some actual news not just reports, there must be some fairly big ticket events happening that would be news worthy but they've released sweet FA for 6 months other than results. There needs to be something to get excited about to make it a worth while investment and they are giving us nothing hence the waning shareprice. | ginko3 | |
28/6/2017 00:01 | They report quarterly, what more do you want? | crazycoops | |
27/6/2017 13:17 | Its now been 6 months since any real news wtf is BXP doing, no wonder the share price performance is so lacklustre this year | ginko3 | |
20/6/2017 12:36 | Would hope to get confirmation shortly that they've launched the Metformin / Glucophage tablets through their distributor in the US and shortly thereafter, some indication of the level of take-up. | ginko3 | |
17/6/2017 14:06 | I'm also back in now albeit in a small way, didn't quite catch the bottom but in for 60p for just about in profit now; quite happy and able to sit it out for the long term. | ginko3 | |
17/6/2017 00:19 | Good shout... Keeping my powder dry at the moment though. | zcaprd7 | |
15/6/2017 18:17 | Couldn't believe 54p to BUY. So I'm back in here now. 50% discount??? - when there's been agitation for dividend payments to GDR holders? If they go ahead, we'll get one of the highest yields in the market. (about 12% here) Ave discount anyway over the past year has been under 40% (which is too much IMHO anyway). And the co is world class, so over time it's going higher. The mkt is certainly daft at times - delighted in this case! J | jswjsw | |
15/6/2017 17:07 | I bought in here on the dip. I've been waiting ages for a good entry price. great long-term ISA hold IMHO. GL all. | mfhmfh | |
15/6/2017 16:30 | no idea but I used to average down and pick up few at 53 and 54 the odd thing was that drop 10 point on a 37k share traded | jovi1 | |
15/6/2017 15:56 | Whoa! what just happened there? Minus 10p from nowhere | crazycoops | |
09/5/2017 13:56 | I'm sittin and waiting... big rise coming over the next 2 years... also buyout possibility so 0% discount to dhaka, plus more big paying drugs will be in the pipeline £2-£5 in next 2-3 years with very little risk. GLA | greg the grinch | |
02/5/2017 08:51 | Agreed. Decided to lock in my 70% gain. Will probably regret... | zcaprd7 | |
01/5/2017 19:01 | Based on the eps figure and historic prices, BXP is fair at BDT 103-108 (around £1 equivalent). 69p may seem like a big discount, but this has been around 45% for long periods. Over the past week or so this has narrowed to just over 30%, where it is probably fair, IMHO. Can't see the £ strengthening much more, but I worry slightly that Dhaka is retracing. So I sold on Fri - will buy back if we see BDT 100. j | jswjsw | |
01/5/2017 18:20 | Top-line growth and profit look OK but my concern would be that the company is not generating any FCF and hasn't consistently done so. Why are they paying a dividend if they are still investing so heavily in growth? BTW: look at their accounts on the website not the numbers on Stockopedia. (running down short-term investments doesn't count as FCF!) Doesn't mean it is a bad company but it pays to understand what is going on.. | jombaston | |
29/4/2017 21:40 | Figures look decent enough to me. A pity that the company provides figures and no real commentary on current trading or outlook. Certainly not a company that can be accused of over hyping it's prospects to investors! No negatives from Graham Neary and as he points out BXP has a very high stock rank on Stockopedia. I'm happy to keep running a long position here. Dibbs | dibbs | |
28/4/2017 14:08 | there is a brief write up in today's SCVR by Graham Neary | crazycoops | |
28/4/2017 09:59 | Yes - I couldn't make much sense of it. Too many numbers. Maybe the final results will make things clearer. | someuwin | |
28/4/2017 09:49 | Looks good. Hard to get an understanding of future of growth though? | zcaprd7 | |
28/4/2017 08:05 | Pre tax profit up 20% | someuwin | |
27/4/2017 10:52 | £1+ this year is my prediction. | someuwin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions